Saskatoon Cancer Center

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Childhood cancers3 trials
• Multiple myeloma3 trials
• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Glioblastoma1 trial
• Pancreatic cancer1 trial

Phase

• Phase 23 trials
• Phase 33 trials

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed2 trials

Lead sponsor

• Pfizer2 trials
• University of Saskatchewan2 trials
• Canadian Myeloma Research Group1 trial
• Denovo Biopharma LLC1 trial
• European Myeloma Network B.V.1 trial
• and 1 more

Running trials

• Recruiting

  Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

  NCT04276857· University of Saskatchewan· Source

  Contact: Shahid Ahmed

• Active, not recruiting

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  NCT05243797· Phase 3· European Myeloma Network B.V.· Source

• Active, not recruiting

  A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

  NCT05217446· Phase 2· Pfizer· Source

• Active, not recruiting

  A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

  NCT04786028· Phase 2· Canadian Myeloma Research Group· Source

• Recruiting

  A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  NCT05020236· Phase 3· Pfizer· Source

• Recruiting

  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  NCT04920617· Phase 2· ImmunoVaccine Technologies, Inc. (IMV Inc.)· Source

  Contact: Jonathan Glum

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Multiple myeloma1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

  NCT03776071· Phase 3· Denovo Biopharma LLC· Source

• Completed

  Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer

  NCT03407768· University of Saskatchewan· Source